Used as a key intermediate in the synthesis of boron-containing pharmaceuticals, particularly in the development of proteasome inhibitors for cancer treatment. Its boronic acid group enables reversible binding to enzyme active sites, making it valuable in targeted therapies. Also employed in Suzuki-Miyaura cross-coupling reactions for constructing biaryl compounds in medicinal chemistry research.